Detalhe da pesquisa
1.
A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study.
Gastroenterology
; 166(5): 872-885.e2, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320723
2.
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study.
Ann Neurol
; 90(1): 159-169, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34029423
3.
A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma.
Invest New Drugs
; 40(1): 81-90, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34417914
4.
Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression Profile.
Stroke
; 50(11): 3259-3264, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31510897
5.
Clinical laboratory and imaging evidence for effectiveness of agarose-agarose macrobeads containing stem-like cells derived from a mouse renal adenocarcinoma cell population (RMBs) in treatment-resistant, advanced metastatic colorectal cancer: Evaluation of a biological-systems approach to cancer therapy (U.S. FDA IND-BB 10091; NCT 02046174, NCT 01053013).
Chin J Cancer Res
; 30(1): 72-83, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545721
6.
Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics.
Cancer
; 123(19): 3843-3854, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28558150
7.
Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach.
Invest New Drugs
; 32(3): 542-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24526575
8.
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.
Oncogene
; 42(44): 3252-3259, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731056
9.
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial.
Cancer
; 118(22): 5497-506, 2012 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22569804
10.
Twitter Conversations About Pancreatic Cancer by Health Care Providers and the General Public: Thematic Analysis.
JMIR Cancer
; 8(1): e31388, 2022 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323123
11.
A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.
Cancer Med
; 11(22): 4169-4181, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499204
12.
Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomes.
J Thromb Haemost
; 20(9): 2046-2057, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35652416
13.
Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage.
Commun Biol
; 4(1): 785, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168263
14.
Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study.
Cancer Prev Res (Phila)
; 14(11): 1021-1032, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625409
15.
Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with KRAS-Mutated Colorectal Cancer.
Mol Cancer Ther
; 19(5): 1148-1156, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32156785
16.
Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient Outcome.
Clin Cancer Res
; 26(18): 4756-4766, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641434
17.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31592503
18.
Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan.
J Clin Oncol
; 35(24): 2790-2797, 2017 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28548889
19.
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.
J Clin Oncol
; 35(19): 2141-2148, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28291390
20.
Sacituzumab Govitecan, a Novel Antibody--Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma.
Clin Genitourin Cancer
; 14(1): e75-9, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26541586